tumor, solid

Showing 1 - 25 of 41

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tumor, Solid Trial in Nanchong (Radiation: 18F-AlF-FAPi-04, Radiation: 18F-FDG)

Recruiting
  • Tumor, Solid
  • Radiation: 18F-AlF-FAPi-04
  • Radiation: 18F-FDG
  • Nanchong, Sichuan, China
    Affiliated Hospital of North Sichuan Medical College
Nov 6, 2023

Immune Profiling for Cancer Immunotherapy Response

Recruiting
  • Cancer
  • +3 more
  • Methylation Cytometry
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Nov 6, 2023

Cancer, Tumor, Solid, Malignant Tumor Trial (OR502, Cemiplimab)

Not yet recruiting
  • Cancer
  • +6 more
  • (no location specified)
Oct 16, 2023

Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • +13 more
  • (no location specified)
Aug 29, 2023

Glioblastoma, Squamous Cell Carcinoma, Hodgkin Lymphoma Trial (AVM0703, Hydrocortisone, Proton pump inhibitor)

Available
  • Glioblastoma
  • +13 more
  • (no location specified)
Jul 26, 2023

Tumor, Solid Trial in Caen, Lille (RCMI in painting dose on histoscannographic mapping, Standard pan-sinusal IMRT)

Not yet recruiting
  • Tumor, Solid
  • RCMI in painting dose on histoscannographic mapping
  • Standard pan-sinusal IMRT
  • Caen, France
  • +2 more
Jul 5, 2023

Renal Cancer, Tumor, Solid, Kidney Cancer Trial (HistoSonics Edison System)

Not yet recruiting
  • Renal Cancer
  • +4 more
  • HistoSonics Edison System
  • (no location specified)
Apr 18, 2023

Biomarkers of Renal Cancer

Recruiting
  • Renal Cell Carcinoma
  • +3 more
    • Firenze, Italy
    • +3 more
    Mar 14, 2023

    Cancer Pain, Tumor, Solid, Carcinoma Trial in Xinxiang (PCA pump)

    Not yet recruiting
    • Cancer Pain
    • +2 more
    • PCA pump
    • Xinxiang, Henan, China
      The First Affiliated Hospital of Xinxiang Medical University
    Feb 24, 2023

    Cancer, Tumor, Solid, Advanced Solid Tumor Trial in Brussels, Barcelona, Madrid (JK08)

    Recruiting
    • Cancer
    • +6 more
    • Brussels, Belgium
    • +3 more
    Jan 30, 2023

    Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

    Recruiting
    • Tumor
    • +20 more
    • Mobile, Alabama
    • +81 more
    Jan 24, 2023

    Cancer, Tumor, Solid, Advanced Solid Tumor Trial in Houston (NTX-1088, Pembrolizumab)

    Recruiting
    • Cancer
    • +4 more
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center
    Jan 24, 2023

    Tumor, Solid Trial (Indocyanine Green)

    Not yet recruiting
    • Tumor, Solid
    • Indocyanine Green
    • (no location specified)
    Jan 24, 2023

    Tumor, Solid, Tumor, Advanced Solid Tumor Trial in San Antonio, West Valley City (nab-sirolimus)

    Recruiting
    • Tumor, Solid
    • +2 more
    • San Antonio, Texas
    • +1 more
    Dec 14, 2022

    Tumor, Solid Trial in Beijing (68Ga-DOTA-F2 PET/CT and 18F-FDG)

    Recruiting
    • Tumor, Solid
    • 68Ga-DOTA-F2 PET/CT and 18F-FDG
    • Beijing, Beijing, China
      Peking union medical college hospital
    Nov 27, 2022

    Tumor, Solid, Pancreatic Cancer Trial in Chapel Hill (Ulixertinib, Palbociclib)

    Recruiting
    • Tumor, Solid
    • +2 more
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center
    Nov 30, 2022

    Real-time Tumor Localization and Guidance for Radiotherapy Using

    Recruiting
    • Tumor, Solid
    • 4D Planar US Transducer
    • Madison, Wisconsin
      University of Wisconsin, Madison
    Nov 8, 2022

    Tumor, Solid Trial in United States (agenT-797, Approved ICIs)

    Recruiting
    • Tumor, Solid
    • Los Angeles, California
    • +8 more
    Oct 21, 2022

    Tumor Rebiopsy in Children and Recurrent or Progressive Solid

    Active, not recruiting
    • Tumor, Solid
    • Re-biopsy
    • Questionnaire
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Oct 10, 2022

    Tumor, Solid, Positron-Emission Tomography Trial in Xiamen (18F-FDG PET/CT, 68Ga-FAPI-RGD PET/CT)

    Recruiting
    • Tumor, Solid
    • Positron-Emission Tomography
    • 18F-FDG PET/CT, 68Ga-FAPI-RGD PET/CT
    • Xiamen, Fujian, China
      The First Affiliated Hospital of Xiamen University
    Sep 16, 2022

    Cancer, Solid Tumor, Adult, Cancer Metastatic Trial in San Antonio (INV-1120, Pembrolizumab)

    Recruiting
    • Cancer
    • +5 more
    • San Antonio, Texas
    • +1 more
    Aug 18, 2022

    Tumor, Solid, Positron-Emission Tomography Trial in Xiamen (18F-FDG)

    Recruiting
    • Tumor, Solid
    • Positron-Emission Tomography
    • 18F-FDG
    • Xiamen, Fujian, China
      The First affiliated hospital of xiamen university
    Aug 8, 2022

    Renal Cancer, Tumor, Solid, Kidney Cancer Trial (HistoSonics System)

    Not yet recruiting
    • Renal Cancer
    • +4 more
    • HistoSonics System
    • (no location specified)
    Jul 26, 2022